Sept 23 (Reuters) - Theraclion SA ALTHER.PA :
* HALF-YEAR RESULTS 2020
* H1 OPERATING LOSS DECREASES BY 5%, TO - € 2,111K AT JUNE
30,
2020 COMPARED TO € -2,218K AT JUNE 30, 2019
* AS OF DECEMBER 31, 2019, THERACLION HAD CASH OF € 1.4
MILLION
* H1 NET RESULT WAS - € 1,872 K; DOWN ONLY 12%, DESPITE THE
CRISIS
* GIVEN CAUTIOUS ESTIMATE OF SYSTEM SALES IN 2020 WITH A
SECOND
HALF EXPECTED TO BE MORE DYNAMIC THAN THE FIRST, AS WELL AS THE
ISSUANCE OF TRANCHE 2 OF THE FINANCING CONTRACTED IN EARLY 2019
* CONSIDERS THAT IT WILL BE ABLE TO COVER ITS CASH FLOW
NEEDS OVER
THE NEXT 12 MONTHS
* SINCE THE END OF THE CONFINEMENT PERIOD, THERACLION HAS
OBSERVED
A GRADUAL RESUMPTION OF TREATMENTS
* THE RESUMPTION WAS PARTICULARLY STRONG IN JULY AND AUGUST
* DURING THIS HALF-YEAR, THE THERACLION TEAMS SUCCEEDED IN
CONTINUING THE TECHNICAL AND CLINICAL DEVELOPMENT OF THE
SONOVEIN® TREATMENT SOLUTION
Source text : https://bit.ly/2EwXsYE
Further company coverage: ALTHER.PA
(Gdansk Newsroom)
((gdansk.newsroom@thomsonreuters.com; +48 58 7785110;))